Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_assertion description "[(a) ER?(+) breast cancer cells dysfunctional for TP53 which proliferate irrespective of low estrogen and chemical MEK inhibition are likely to increase metabolic consumption becoming increasingly susceptible to 3-BrPA; (b) targeting the pyruvate pathway may improve response to endocrine therapy in ER?(+) breast cancer with p53 dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_assertion evidence source_evidence_literature NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_assertion SIO_000772 24486524 NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_assertion wasDerivedFrom befree-2016 NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_assertion wasGeneratedBy ECO_0000203 NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1151088.RAPbB2tcaPFjEBbSDPOmPlnwvYPx2i2BIAWg17jxctmZU130_provenance.